Volume 30, Number 10—October 2024
Dispatch
Mpox Epidemiology and Vaccine Effectiveness, England, 2023
Table 1
Available demographic characteristics of mpox case-patients, England, 2022 and 2023*
Variable | Year, no, (%) |
|
---|---|---|
2022, n = 3,412† | 2023, n = 137 | |
Region | ||
London | 2,359 (69) | 105 (77.0) |
Outside London | 1,040 (30) | 32 (23.0) |
Unknown |
13 (0.4) |
0 |
Sex | ||
M | 3,345 (98) | 135 (99.0) |
F | 45 (1.3) | 1 (0.7) |
Unknown |
22 (0.6) |
1 (0.7) |
Sexual orientation GBMSM | 983 (97)‡ | 128 (93)§ |
*Patients were median 36 years of age for both years (IQR 30–44 y in 2022 and 29–43 y in 2023). IQR, interquartile range; GBMSM, gay, bisexual, and other men who have sex with men. †May 6–Sep 16, 2022 (1). ‡Obtained via enhanced surveillance questionnaires, which were complete for 31% of case-patients by September 18, 2022. §107 case-patients self-identified identifying as GBMSM plus 21 who were adult men without recorded information on sexual orientation and no travel to mpox-endemic countries in Central or West Africa but were presumed to be part of the outbreak.
References
- UK Health Security Agency. Mpox (monkeypox) outbreak: epidemiological overview [cited 2024 Feb 14]. https://www.gov.uk/government/publications/monkeypox-outbreak-epidemiological-overview
- UK Health Security Agency. Mpox (monkeypox): case definitions [cited 2024 Feb 14]. https://www.gov.uk/guidance/monkeypox-case-definitions
- UK Health Security Agency. Reporting to UKHSA: a guide for diagnostic laboratories [cited 2024 Feb 14]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1159953/UKHSA_Laboratory_reporting_guidelines_May_2023.pdf
- UK Health Security Agency. Notifiable diseases and causative organisms: how to report [cited 2024 Feb 14]. https://www.gov.uk/guidance/notifiable-diseases-and-causative-organisms-how-to-report
- Flannery B, Andrews N, Feikin D, Patel MK. Commentary: Estimation of vaccine effectiveness using the screening method. Int J Epidemiol. 2023;52:19–21. DOIPubMedGoogle Scholar
- Bertran M, Andrews N, Davison C, Dugbazah B, Boateng J, Lunt R, et al. Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study. Lancet Infect Dis. 2023;23:828–35. DOIPubMedGoogle Scholar
- UK Health Security Agency. HIV action plan monitoring and evaluation framework [cited 2024 Apr 25]. https://www.gov.uk/government/publications/hiv-monitoring-and-evaluation-framework
- Chicago Health Alert Network. Potential risk for new mpox cases—provider update: May 9, 2023 [cited 2024 Feb 14]. https://emergency.cdc.gov/han/2023/han00490.asp
- Chicago Department of Public Health. Mpox dashboard [cited 2024 Feb 14]. https://www.chicago.gov/city/en/depts/cdph/provdrs/infectious_disease/supp_info/mpox-home/mpox-dashboard.html
- World Health Organization. Multi-country outbreak of mpox: external situation report #31—22 December 2023 [cited 2024 Feb 14]. https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox--external-situation-report-31---22-december-2023